Lu-177-ITM-31
177Lu-ITM-31 (177Lu-LuCaFab) is a carbonic anhydrase XII-specific antibody Fab fragment. [...]
Lu-177-DPI-4452
177Lu-DPI-4452 is a 177Lu labeled peptide developed for the treatment [...]
Lu-177-DOTA-EB-FAPi
177Lu-DOTA-EB-FAPi is a new therapeutic agent from the FAPi family. [...]
Lu-177-AMTG
177Lu-AMTG is a radiolabeled bombesin analogue developed at the Technical [...]
Lu-177-HTK03170
177Lu-HTK03170 is the therapeutic 177Lu-labeled analogue of 68Ga-HTK03149, itself based [...]
Lu-177-Rituximab
177Lu-Rituximab is the Lutetium-177 labeled analogue of 131I-Tositumomab (131I-Bexxar) for [...]
Lu-177-PSMA-ALB-56
177Lu-PSMA-ALB-56 is a radiolabeled PSMA analogue developed for prostate cancer [...]
Lu-177-PNT6555
177Lu-PNT6555 (part of the PNT2004 development program) is a molecule [...]
Y-90-Tabituximab barzuxetan
90Y-Tabituximab barzuxetan (90Y-OTSA101-DTPA) is a radiolabeled drug based on an [...]
Ac-225-FPI-2059
225Ac-FPI-2059 (225Ac-3BP-227, 225Ac-IPN-01087) is the 225Ac-labeled analogue of 177Lu-IPN-1087, a [...]